
Our attorneys have extensive expertise representing investors in securities litigation with a track record of recovering hundreds of millions of dollars in cases. The firm, with more than 80 employees, is committed to fostering, cultivating and preserving a culture of diversity, equity and inclusion for employees and those that we represent. The Firm's Founding Partners, Joseph Levi and Eduard Korsinsky, have been representing shareholders and institutional clients for almost 20 years and have achieved remarkable results for clients in the U.S. Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington, D.C. We represent and fight for shareholders who have been wronged by corporations. WHY LEVI & KORSINSKY: Levi & Korsinsky have a proven track record of winning cases worth hundreds of millions of dollars for shareholders over a 20-year period. PROTECT YOUR FINANCIAL INTERESTS: Complete this brief submission form or call 21 to discuss the case with Joseph E. NO COST TO YOU: If you purchased Amarin securities between Decemand June 21, 2021, you may be entitled to compensation without payment of any out-of-pocket costs or fees. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. WHAT THIS MEANS TO SHAREHOLDERS: If you suffered a loss in Amarin, you have until December 23, 2021 to request that the Court appoint you as lead plaintiff. There is no cost or obligation to you.ĬASE DETAILS: According to the filed complaint: (i) there was an increasingly high risk that certain of Amarin's patents would be invalidated (ii) once the District Court invalidated certain of Amarin's patents, there was little to no chance of reversing that ruling (iii) the Company's litigation was preventing it from effectuating a successful takeover (iv) Defendants were downplaying the true threat the ongoing abbreviated new drug application litigation posed to the Company's business and future prospects and (v) as a result, the Company's public statements were materially false and misleading at all relevant times. either via email at by telephone at (212) 363-7500.


You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the District of New Jersey. To: All persons or entities who purchased or otherwise acquired securities of Amarin Corporation Plc ("Amarin") (NASDAQ: AMRN) between Decemand June 21, 2021.
